Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections |
Recalls
- Oct 1, 2019 · Class II · Dr. Reddy's Laboratories, Inc.
CGMP Deviations: Presence of NDMA impurity detected in product.
Lots: Batch Numbers: All lots within expiry. - Oct 1, 2019 · Class II · Dr. Reddy's Laboratories, Inc.
CGMP Deviations: Presence of NDMA impurity detected in product.
Lots: Batch Numbers: All lots within expiry.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ranitidine: every company that makes it
- Form
- capsule, oral
- Strength
- 300 mg
- Approval
- ANDA ANDA075742
- On the market since
- Apr 1, 2001
- Package NDCs
55111-130-0155111-130-30- Official label
- DailyMed (National Library of Medicine), updated Nov 21, 2018
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?